These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9885798)

  • 21. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
    Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
    Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
    Motulsky HJ; Insel PA
    Biochem Pharmacol; 1982 Aug; 31(16):2591-7. PubMed ID: 6291538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
    Faludi G; Tekes K; Tóthfalusi L
    J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers.
    Stein MB; Delaney SM; Chartier MJ; Kroft CD; Hazen AL
    Biol Psychiatry; 1995 Feb; 37(4):224-8. PubMed ID: 7711158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment.
    Weizman R; Laor N; Schujovitsky A; Wolmer L; Abramovitz-Schnaider P; Freudstein-Dan A; Rehavi M
    Psychiatry Res; 1996 Jul; 63(2-3):143-50. PubMed ID: 8878310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
    Lawrence KM; Katona CL; Abou-Saleh MT; Robertson MM; Nairac BL; Edwards DR; Lock T; Burns RA; Harrison DA; Horton RW
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):261-4. PubMed ID: 7862905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
    Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive behaviour and platelet 3H-paroxetine binding in schizophrenia.
    Maguire K; Cheung P; Crowley K; Norman T; Schweitzer I; Burrows G
    Schizophr Res; 1997 Jan; 23(1):61-7. PubMed ID: 9050129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
    Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
    Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lesioning of serotoninergic and noradrenergic nerve fibres of the rat brain does not decrease binding of 3H-clonidine and 3H-rauwolscine to cortical membranes.
    Gross G; Göthert M; Glapa U; Engel G; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):229-35. PubMed ID: 2984581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients.
    Marazziti D; Dell'Osso B; Baroni S; Betti L; Catena M; Giannaccini G; Lucacchini A; Cassano GB
    Pharmacopsychiatry; 2006 Jan; 39(1):35-8. PubMed ID: 16453253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of serotonin transporters in blood platelets after epileptic seizures.
    Cupello A; Favale E; Audenino D; Scarrone S; Gastaldi S; Albano C
    Neurochem Res; 2005 Apr; 30(4):425-8. PubMed ID: 16076011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD.
    Rasmusson AM; Hauger RL; Morgan CA; Bremner JD; Charney DS; Southwick SM
    Biol Psychiatry; 2000 Mar; 47(6):526-39. PubMed ID: 10715359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of tryptophan/large neutral amino acids ratio to antidepressant response.
    Lucini V; Lucca A; Catalano M; Smeraldi E
    J Affect Disord; 1996 Jan; 36(3-4):129-33. PubMed ID: 8821315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.
    Malison RT; Price LH; Berman R; van Dyck CH; Pelton GH; Carpenter L; Sanacora G; Owens MJ; Nemeroff CB; Rajeevan N; Baldwin RM; Seibyl JP; Innis RB; Charney DS
    Biol Psychiatry; 1998 Dec; 44(11):1090-8. PubMed ID: 9836013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.